BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 26733416)

  • 41. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models.
    Faldini E; Ahmed T; Bueé L; Blum D; Balschun D
    Acta Neuropathol Commun; 2019 Dec; 7(1):202. PubMed ID: 31815648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
    Tamano H; Takeda A
    Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau is not necessary for amyloid-β-induced synaptic and memory impairments.
    Puzzo D; Argyrousi EK; Staniszewski A; Zhang H; Calcagno E; Zuccarello E; Acquarone E; Fa' M; Li Puma DD; Grassi C; D'Adamio L; Kanaan NM; Fraser PE; Arancio O
    J Clin Invest; 2020 Sep; 130(9):4831-4844. PubMed ID: 32544084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
    Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
    Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuronal p38α mediates synaptic and cognitive dysfunction in an Alzheimer's mouse model by controlling β-amyloid production.
    Colié S; Sarroca S; Palenzuela R; Garcia I; Matheu A; Corpas R; Dotti CG; Esteban JA; Sanfeliu C; Nebreda AR
    Sci Rep; 2017 Mar; 7():45306. PubMed ID: 28361984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
    Roberson ED; Halabisky B; Yoo JW; Yao J; Chin J; Yan F; Wu T; Hamto P; Devidze N; Yu GQ; Palop JJ; Noebels JL; Mucke L
    J Neurosci; 2011 Jan; 31(2):700-11. PubMed ID: 21228179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-Dependent Decline in Synaptic Mitochondrial Function Is Exacerbated in Vulnerable Brain Regions of Female 3xTg-AD Mice.
    Espino de la Fuente-Muñoz C; Rosas-Lemus M; Moreno-Castilla P; Bermúdez-Rattoni F; Uribe-Carvajal S; Arias C
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
    Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
    Elife; 2017 Jul; 6():. PubMed ID: 28696204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synaptic Alterations in Mouse Models for Alzheimer Disease-A Special Focus on N-Truncated Abeta 4-42.
    Dietrich K; Bouter Y; Müller M; Bayer TA
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29561816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
    Hwang J; Estick CM; Ikonne US; Butler D; Pait MC; Elliott LH; Ruiz S; Smith K; Rentschler KM; Mundell C; Almeida MF; Stumbling Bear N; Locklear JP; Abumohsen Y; Ivey CM; Farizatto KLG; Bahr BA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.
    Trujillo-Estrada L; Vanderklish PW; Nguyen MMT; Kuang RR; Nguyen C; Huynh E; da Cunha C; Javonillo DI; Forner S; Martini AC; Sarraf ST; Simmon VF; Baglietto-Vargas D; LaFerla FM
    Neurotherapeutics; 2021 Oct; 18(4):2468-2483. PubMed ID: 34738197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.